{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:26:47Z","timestamp":1776130007542,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2020,6,18]],"date-time":"2020-06-18T00:00:00Z","timestamp":1592438400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Acta Obstet Gynecol Scand"],"published-print":{"date-parts":[[2020,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>In Norway, all patient\u2010reported claims for compensation are evaluated by The Norwegian System of Patient Injury Compensation (NPE). The number of claims from women with cervical cancer is rising, and the approval rate is high. Our aim was to study claims for compensation from women with cervical cancer to identify the type of failures, when, during the time\u2010course of treatment, the medical failures occurred, and the consequences of the failures.<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>A retrospective, descriptive study of claims for compensation to NPE from cervical cancer patients during a 12\u2010year period, from 2007 through 2018. We used anonymized medical expert statements and summaries of NPE cases.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In all, 161 women claimed compensation for alleged medical failure related to cervical cancer. Compensation was approved for 100 (62%) women. Mean age at the time of alleged failure was 37.5\u00a0years (SD \u00b19.9). The main reasons why women sought medical attention were routine cervical screening (56%), or vaginal bleeding or discharge (30%). In approved cases, incorrect evaluation of cytology and histology was the cause of most failures (72%). Mean delay of cervical cancer diagnosis for approved cases was 28\u00a0months (SD \u00b122). Treatment not in accordance with guidelines was the cause of failure in 2% of the cases, and failure during follow up was the cause of failure in 12%. Consequences of the failures were as follows: worsening of cancer prognosis (89%), treatment\u2010induced adverse effects, such as loss of fertility (43%) and\/or loss of ovarian function in premenopausal women (50%), and permanent injury after chemo\u2010radiation (27%). Seven women (7%) died, most probably as a consequence of the failure.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The main cause of medical failure in women with cervical cancer was incorrect pathological diagnosis. The main consequences of failures were worsening of cancer prognosis and treatment\u2010induced adverse effects. Increased focus on the quality of pathological examinations, and better routines in all parts of the cervical examinations might improve patient safety for women in risk of cervical cancer.<\/jats:p><\/jats:sec>","DOI":"10.1111\/aogs.13930","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T12:56:48Z","timestamp":1591189008000},"page":"1546-1553","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Claims for compensation from women with cervical cancer in Norway\u2014A retrospective, descriptive study of a 12\u2010year period"],"prefix":"10.1111","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2173-5482","authenticated-orcid":false,"given":"Merethe","family":"Ravlo","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Medicine Norwegian University of Science and Technology Trondheim Norway"},{"name":"Department of Obstetrics and Gynecology St. Olav's Hospital University Hospital of Trondheim Trondheim Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marit","family":"Lieng","sequence":"additional","affiliation":[{"name":"Department of Gynecology Oslo University Hospital Oslo Norway"},{"name":"Institute of Clinical Medicine University of Oslo Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ida Rashida","family":"Khan Bukholm","sequence":"additional","affiliation":[{"name":"Norwegian System of Patient Injury Compensation Oslo Norway"},{"name":"Norwegian University of Life Sciences (NMBU) Oslo Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6013-2409","authenticated-orcid":false,"given":"Mette","family":"Haase Moen","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine Norwegian University of Science and Technology Trondheim Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eszter","family":"Vanky","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine Norwegian University of Science and Technology Trondheim Norway"},{"name":"Department of Obstetrics and Gynecology St. Olav's Hospital University Hospital of Trondheim Trondheim Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2020,6,18]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.13605"},{"key":"e_1_2_10_3_1","unstructured":"Cancer in Norway 2017.https:\/\/www.kreftregisteret.no\/globalassets\/cancer\u2010in\u2010norway\/2017\/cin\u20102017.pdf(Accessed October 28 2019)"},{"key":"e_1_2_10_4_1","unstructured":"WHO.Human reproductive program research for impact| WHO leads the way towards the elimination of cervical cancer as a public health concern.https:\/\/www.who.int\/reproductivehealth\/cervical\u2010cancer\u2010public\u2010health\u2010concern\/en\/(Accessed October 28 2019)"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32195"},{"key":"e_1_2_10_6_1","unstructured":"Kreftregisteret.Fakta om masseunders\u00f8kelsen mot livmorhalskreft (cervixscreeningprogrammet). [Facts about mass cervical cancer screening (cervical screening program)]. In Norwegian.https:\/\/www.kreftregisteret.no\/Generelt\/Nyheter\/Fakta\u2010om\u2010Masseundersokelsen\u2010mot\u2010livmorhalskreft\u2010eller\u2010Cervixscreeningprogrammet\/(Accessed October 28 2019)"},{"key":"e_1_2_10_7_1","unstructured":"NIPH.Norwegian Institute of Public Health. HPV vaccine for young women.https:\/\/www.fhi.no\/en\/id\/vaccines\/hpv\u2010vaccine\/(Accessed October 28 2019)"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i2139"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.070690"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1159\/000346296"},{"key":"e_1_2_10_11_1","unstructured":"WHO.World alliance for patient safety. Summary of the Evidence on Patient Safety: Implications for Research.https:\/\/www.who.int\/patientsafety\/information_centre\/Summary_evidence_on_patient_safety.pdf(Accessed October 28 2019)"},{"key":"e_1_2_10_12_1","unstructured":"NPE.What are the criteria to qualify for compensation for a patient injury?https:\/\/www.npe.no\/en\/information\u2010compensation\u2010claimants\/information\u2010making\u2010application\u2010patient\u2010injury\/criteria\u2010to\u2010qualify\u2010for\u2010compensation\/(Accessed October 28 2019)"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1191\/0267659105pf812oa"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1136\/qshc.2005.015743"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzv084"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.16.0435"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.16.0368"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2007.06.007"},{"key":"e_1_2_10_19_1","unstructured":"KristiansenI.Dagens Medisin June 9 2017. B\u00f8r kvinner f\u00e5 informasjon om \u00abfeiltolkede\u00bb livmorhalskreftpr\u00f8ver? [Should women get information on \"misinterpreted\" cervical cancer tests?] In Norwegian.https:\/\/www.dagensmedisin.no\/blogger\/ivar\u2010sonbo\u2010kristiansen\/2017\/06\/09\/bor\u2010kvinner\u2010fa\u2010informasjon\u2010om\u2010feiltolkede\u2010livmorhalskreftprover\/(Accessed October 28 2019)"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/his.13760"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djy225"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.320.7246.1352"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1258\/0956462053420266"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp14X681757"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2015.0055"},{"key":"e_1_2_10_26_1","unstructured":"Norsk gynekologisk forening.Veiledere legeforeningen.no. [Norwegian doctors\u2019 association guides]. In Norwegian.http:\/\/legeforeningen.no\/Fagmed\/Norsk\u2010gynekologisk\u2010forening\/Veiledere\/(Accessed October 28 2019)"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2006.03.050"},{"key":"e_1_2_10_28_1","unstructured":"Folkehelseinstituttet.Barnevaksinasjonsprogrammet\u2014veileder for helsepersonell. [Child Vaccination Program\u2014Guide for Healthcare Professionals.]. In Norwegian.https:\/\/www.fhi.no\/nettpub\/vaksinasjonsveilederen\u2010for\u2010helsepersonell\/vaksinasjon\/barnevaksinasjonsprogrammet\/#historisk\u2010oversikt(Accessed October 28 2019)"},{"key":"e_1_2_10_29_1","unstructured":"Folkehelseinstituttet.Fem \u00e5r etter innf\u00f8ring av HPV vaksine: Stor nedgang i forekomst av HPV. [Five years after the introduction of HPV vaccine: Large decrease in the incidence of HPV.]In Norwegian.https:\/\/www.fhi.no\/nyheter\/2018\/fem\u2010ar\u2010etter\u2010innforing\u2010av\u2010hpv\u2010vaksine\u2010stor\u2010nedgang\u2010i\u2010forekomst\u2010av\u2010hpv\/(Accessed October 28 2019)"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2017.06.003"}],"container-title":["Acta Obstetricia et Gynecologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Faogs.13930","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aogs.13930","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/aogs.13930","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/aogs.13930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T13:32:43Z","timestamp":1692883963000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/aogs.13930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,18]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["10.1111\/aogs.13930"],"URL":"https:\/\/doi.org\/10.1111\/aogs.13930","archive":["Portico"],"relation":{},"ISSN":["0001-6349","1600-0412"],"issn-type":[{"value":"0001-6349","type":"print"},{"value":"1600-0412","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,18]]},"assertion":[{"value":"2019-11-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}